In Brief
Afferents to ventral tegmental area (VTA) neurons control reward-seeking behaviors, but their relative arrangement onto heterogeneous VTA cell types has remained largely unknown. Faget et al. now use an optimized transsynaptic retrograde tracing approach to provide a comprehensive map of inputs to each transmitter-defined VTA cell type.
INTRODUCTION
The ventral tegmental area (VTA) and its cortical, striatal, and limbic projections are key circuits involved in encoding, energizing, and adapting behavioral responses to salient stimuli. A thorough understanding of the input-output VTA network is required for our comprehension of addiction and other maladaptive behavioral disorders. Like many brain areas, cells in the VTA do not represent a homogenous structure but are rather highly heterogeneous, whether organized across anatomical, neurochemical, or functional domains (Fields et al., 2007; Lammel et al., 2014) . One fundamental source of heterogeneity is the neurotransmitter identity and the constellation of gene products required to synthesize, package, release, and reuptake recycling neurotransmitters. Although dopamine neurons in the VTA are the best studied, GABA-and glutamate-releasing neurons are also abundant, as are neurons capable of co-releasing combinations of these. The recent demonstration that VTA neurons express vesicular glutamate transporter 2 (VGLUT2) (Kawano et al., 2006) and the ability of some dopamine neurons to co-release glutamate (Chuhma et al., 2014; Hnasko et al., 2010; Stuber et al., 2010; Tecuapetla et al., 2010) have led to a surge of interest in VTA glutamate neurons. We and others have begun to characterize their physiological properties, projection targets, and functional roles (Alsiö et al., 2011; Root et al., 2014; Taylor et al., 2014) . However, the afferent inputs to VTA glutamate neurons and how the inputs compare to VTA dopamine and GABA neurons remain unknown.
Retrograde tracing has been widely used to map sources of afferent input from a target brain region. However, classical tracers such as horseradish peroxidase or fluorogold do not readily discriminate based on cell type. Several rabies-or herpes-based viral vectors have been developed that target genetically defined cell types and spread transsynaptically to label afferent inputs (Callaway, 2008; Card and Enquist, 2014; Wall et al., 2010; Wickersham et al., 2007) . Combined use of modified rabies virus (Rb) together with ''helper'' adeno-associated virus (AAV) vectors has proven particularly amenable toward this goal across a variety of structures and neuron types (Wall et al., 2013; Weissbourd et al., 2014) . Indeed, recent studies have used such approaches to characterize inputs onto VTA or substantia nigra dopamine neurons Lerner et al., 2015; Menegas et al., 2015; Ogawa et al., 2014; Watabe-Uchida et al., 2012) .
Here, we compare the afferent inputs to genetically defined VTA glutamate, dopamine, and GABA neurons using mCherryexpressing and glycoprotein-deleted rabies virus pseudotyped with an EnvA envelope protein . This vector was used in combination with optimized helper AAVs that allow for more accurate assessment of ''starter cells,'' enhancement of transsynaptic spreading, and titration to reduce leakage. Our analysis of VTA inputs indicates that all the major sources of VTA input target each of the transmitter-defined cell types. For example, irrespective of VTA cell type, the dorsal raphe (DR) and lateral hypothalamus (LH) provided the greatest number of cells with afferent connections. Inputs to VTA glutamate neurons were similar to inputs to VTA dopamine (B) Schematic illustrating strategy to achieve cell-type-specific transsynaptic tracing. Expression of TVA receptors (green) and RbG-hBFP (blue nuclei) is Cre dependent. EnvA-Rb-DG-mCherry initially infects TVA-expressing cells and relies on RbG-hBFP expression for transsynaptic spread to afferent inputs. Cre-positive starter cells are defined as those expressing both RbG (BFP) and Rb (mCherry).
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2 Cell Reports 15, 1-13, June 21, 2016 neurons, but glutamate cells received proportionally less input from ventral striatal regions. Still largely similar, the VTA GABA and dopamine neurons proved most distinct, with dopamine neurons again receiving input from proportionally more striatal neurons and GABA neurons receiving proportionally more from lateral habenula (LHb) and hindbrain nuclei. By mapping the afferents to each of the three major transmitter-defined VTA cell populations, this study allows for a more thorough understanding of the functional relevance of VTA inputs and outputs in addiction and motivational processes.
RESULTS
Previous work has used Rb-based approaches to assess celltype-specific afferent inputs to midbrain dopamine neurons Lerner et al., 2015; Menegas et al., 2015; Watabe-Uchida et al., 2012) . Here, we compare whole-brain inputs to each of three populations of VTA cell types defined by their recycling neurotransmitter. To define afferents to genetically identified VTA glutamate neurons, we used knockin mice expressing Cre recombinase under the control of the Slc17a6 locus (vesicular glutamate transporter; VGLUT2-IRES-Cre). To compare glutamate-releasing neurons with neighboring populations of dopamine or GABA neurons in the VTA, we used Slc6a3 (dopamine transporter; DAT-IRES-Cre) or Slc32a1 knockin mice (vesicular GABA transporter, VGAT-IRES-Cre).
Strategy for Labeling Inputs to Defined VTA Cell Types and Key Controls
To enable selective visualization of primary inputs to neurotransmitter-defined populations, we used a modified Rb EnvA-Rb-DG-mCherry (hereafter called Rb-mCherry) in combination with two improved Cre-dependent helper viruses. Rb-mCherry was modified to delete the rabies glycoprotein (RbG) from the viral genome to prevent transsynaptic spreading and in its place inserted a mCherry fluorescent tag. To restrict initial cellular transduction, Rb was pseudotyped with the avian sarcoma leukosis virus coat protein EnvA, thus requiring the presence of an avian TVA receptor for primary transduction. To allow for cell-typerestricted transduction and subsequent transsynaptic propagation of the modified Rb, mice first received stereotactic injections of two optimized helper AAV vectors. The first, AAV2/1-eSyn-DIO-TVA950:YFP (hereafter referred to as AAV-TVA), allows for initial cellular transduction of EnvA-pseudotyped Rb via Cre-dependent expression of an avian TVA receptor fused with yellow fluorescent protein (TVA:YFP). A second, AAV2/1-EF1a-DIO-H2B-tagBFP-FLAGx3-T2Am-cB19G (hereafter referred to as AAV-RbG), was mixed with the first and permits retrograde transsynaptic spread by driving Cre-dependent co-expression of the RbG plus a nuclear reporter. To increase efficiency of transsynaptic spreading and reliably detect starter cells, we made three modifications to the H2B-GFP-F2A-B19G cassette used in previous studies . The cassette H2B-tagBFP-FLAGx3-T2Am-cB19G included (1) codon optimization to increase RbG expression for trans-complementation of Rb-DG, (2) a distinctly colored FLAG-tagged histone-bound blue fluorescent protein (BFP) for labeling starter cells, and (3) enhanced multicistronic expression using the improved 2A element T2Am. Three weeks after delivery of the helper virus to the VTA, Rb-mCherry was injected at the same site to infect primary Cre-expressing starter cells in the VTA. One week later, mice were sacrificed and whole brains sectioned to identify inputs ( Figures 1A and 1B) .
However, to verify the specificity of the strategy, we performed three essential control experiments. First, to determine if the modified Rb-mCherry relies exclusively on TVA for initial cellular transduction, we injected Rb-mCherry without prior injection of the helper AAVs. This is an important control to ensure that each batch of pseudotyped Rb is not functionally contaminated with RbG-coated Rb, although we confirmed no infection of HEK293t cells with the EnvA-pseudotyped Rb-mCherry used for in vivo injection. In five animals injected and brains sectioned, we never detected mCherry + cells ( Figure S1A ), demonstrating that the EnvA pseudotyping entirely prevented Rb-mCherry entry absent cellular TVA expression. Leakage of the TVA-expressing helper virus in non-Cre-expressing cells was encountered in previous studies (WatabeUchida et al., 2012) . Even though leak TVA expression may be undetectable by immunochemistry, it can be revealed by our second control experiment where we injected both AAV helpers at ''stock'' concentrations (i.e., greater than 2 3 10 12 ) into Crenegative wild-type (WT) mice prior to injection of the Rb-mCherry (n = 2). In WT mice, we observed substantial mCherry + cells in the VTA ( Figure S1B ). This, despite no observed TVA:YFP (or hBFP) fluorescence ( Figure S1B ), suggests a very low ''leak'' expression of TVA:YFP independent of Cre-mediated recombination, thereby allowing for Rb entry via high-affinity interaction of TVA with EnvA followed by Rb amplification. Importantly, and consistent with previous observations, we saw no evidence of Rbdriven mCherry expression outside of the immediate injection sites, indicating that transsynaptic spread does not occur absent robust RbG expression. Nonetheless, the presence of large numbers of mCherry + cells near the injection site in WT mice limits identification of local or proximal connections. Because very little TVA expression is required for initial transduction, we reasoned that dilution of the AAV-TVA would allow us to identify conditions under which injection into WT mice led to few mCherry + cells, while injection into Cre-expressing mice led to labeling of many cells. Indeed, a 1:2,000 dilution of stock AAV-TVA (i.e., 200 nl at 2.4 3 10 10 genomes/ml) led to minimal mCherry-labeling in the VTA of WT controls ( Figure S1B ) in comparison to Cre + mice ( Figure 1C ).
In some circuits, some preparations of AAV can drive gene expression in afferent populations of neurons, presumably by AAV transduction of terminals and retrograde transport to cell bodies (Castle et al., 2014; Menegas et al., 2015; Watabe-Uchida et al., 2012) . It is thus possible that Cre + cells that project to VTA may express low levels of TVA via the retrograde AAV mechanism. Even low levels of TVA, if trafficked to nerve terminals in the VTA, may allow for Rb transduction and mCherry expression. Such a phenomenon would invalidate our ability to define inputs to specific VTA cell types, because VGLUT2-Cre + or VGAT-Cre + neurons in afferent regions could express mCherry irrespective of which cell type they target. Thus, for our third control experiment, we injected diluted AAV-TVA without the second helper, AAV-RbG, into groups of VGLUT2-, DAT-, or VGAT-Cre mice (n = 3/genotype). Three weeks later, we injected Rb-mCherry and, as expected, observed mCherry + cells in the VTA. However, in regions known to receive input from VTA neurons, we identified only mCherry + fibers ( Figure S1C ); no mCherry-expressing cell bodies were detected distal to the site of injection (Figure S1C) . We therefore conclude that using our conditions, any retrograde transport of AAV-TVA is insufficient to allow for direct Rb-mCherry transduction following VTA injection.
Identification of VTA ''Starter'' Cell Types Defined by Transmitter Mice expressing Cre under the control of VGLUT2 (n = 6), DAT (n = 6), or VGAT (n = 5), as well as WT mice (n = 4) were each injected with diluted AAV-TVA and AAV-RbG into the VTA. Three weeks later, they were injected with Rb-mCherry into the same location and sacrificed 1 week later ( Figure 1A ). Starter cells were identified as cells expressing both the RbG (defined as nuclear hBFP + ) and mCherry ( Figure 1C ). We defined starter cells thus because it is the expression of the RbG that allows Rb to shed and spread transsynaptically. Zero starter cells were detected in WT mice, and mice with starter cells best restricted to VTA were included in the cell counts (n = 3-4 per genotype) ( Figures 1D and 2 ). In all included cases, >90% of starter cells were located within the VTA (Data S1). Anatomical specificity of the starter cell population was important for all cell types but arguably most critical for the VGAT-Cre mice, where spread into the GABA-neuron-rich interpeduncular nucleus (IP) led to massive Rb-mCherry expression in the medial habenula (MHb) ( Figure S2 ). Though an equivalent number of starter cells were labeled across the three genotypes, VTA glutamate neurons appeared to receive more inputs per starter cells (27.8 ± 5.1 input cells/starter cell) than GABA neurons (14.1 ± 0.9), with VTA dopamine neurons intermediate (20.8 ± 3.7) ( Figures 1F and 1G ).
To verify that starter cells appropriately represented transmitter-defined cell types, we stained sections through the VTA for the dopamine neuron marker tyrosine hydroxylase (TH). Because native BFP fluorescence was particularly sensitive to immunohistochemical procedures and showed more pronounced photobleaching upon imaging, we co-labeled for the FLAG epitope to better visualize nuclear BFP expression. As expected, 97.6% ± 1.2% of starter cells in DAT-Cre mice were TH + ( Figures 2B and 2E ). We found that 18.4% ± 4.5% of VGLUT2-Cre starter cells were TH + (Figures 2A, 2E , and 2F), consistent with numerous reports demonstrating overlap of TH with VGLUT2 expression and co-release of dopamine with glutamate (Hnasko et al., 2010; Stuber et al., 2010; Yamaguchi et al., 2011) . Finally, consistent with previous evidence demonstrating that canonical GABAergic markers do not appreciably co-localize with dopaminergic markers (Chieng et al., 2011) , only 0.3% ± 0.2% of the VGAT-Cre starter cells were TH + ( Figures 2C and 2E ). Figure S2 ). Examples of major inputs across cell type are shown in Figure 3 . Compared to other cell types, VTA glutamate neurons received more input per starter cell from cortex, dopamine neurons received more inputs per starter cell from striatum, and GABA neurons tended to receive less input overall when considered as a function of starters ( Figure 3H ). However, interpretation of input data normalized by starter cells is complicated by the distinct possibility of convergent inputs, resulting in fewer inputs per starter cell as the number of starter cells increase. This can be visualized as shallower slopes, notably for inputs/starter to VTA GABA neurons ( Figures 3A-3G ). Thus, we also calculated the total fraction of input each cell type receives as a fraction of all inputs to that cell type; e.g., calculating that just 3.6% ± 0.3% of all inputs to dopamine neurons come from cortical regions. These data can then be represented and considered in a variety of ways, although it is essential to hold in mind that the number of cells making afferent connections (inputs) to a defined VTA cell type need not denote functional significance. Spreadsheets with all cell counts broken down by brain areas, sub-areas, and regions are provided in Data S1.
Identification of Inputs to
We found that all of the main inputs to VTA project to each of the transmitter-defined cell types ( Figures 4A and 4B ). These results are consistent with recent observations by others examining inputs to projection-target defined dopamine neurons Watabe-Uchida et al., 2012) and indicate that inputs to the VTA are not qualitatively constrained by VTA cell type. However, even at the macro level of brain area, quantitative differences begin to emerge. For example, VTA dopamine neurons receive a higher proportion of their input from striatal areas, whereas VTA GABA neurons receive a greater proportion of their input from thalamic and hindbrain regions (Figures 4A and 4B) . These data also indicate that most afferent control over VTA neurons arises from outside the telencephalon. For example, the midbrain, hindbrain, and hypothalamus represent a combined 68% ± 3%, 75% ± 3%, and 78% ± 1% of all inputs to, respectively, VTA dopamine, glutamate, or GABA neurons. Of course, these brain areas include many sub-areas, each composed of multiple discrete regions, many of which are themselves heterogeneous.
Dissecting these macro brain areas into the 25 sub-areas and regions that provided the greatest share of input (i.e., 75%-80% of the total VTA input) revealed additional distinctions ( Figures  4C, 4D , and 5). For example, each of the three striatal regions examined as well as the globus pallidus (LGP) preferentially targeted dopamine neurons. Cortical regions tended to preferentially target VGLUT2 + neurons. Neurons in the LHb displayed a clear preference for VGAT + neurons in the VTA, though they did not entirely avoid dopamine or glutamate cells. Also notable, VGAT + neurons received proportionally more input from the laterodorsal tegmental nucleus (LDTg) and raphe magnus nucleus (RMg). Many other regions also provide input to VTA, though no other regions represented >1% of the total input; for a detailed list of regions and percentages of inputs, see Data S1.
Immunochemical Characterization of VTA Afferents by Cell Type
The largest source of VTA input from the telencephalon was from the ventral pallidum (VP), providing 6.1% ± 1.5%, 5.3% ± 0.5%, and 4.3% ± 0.3% of total input to VTA dopamine, glutamate, and GABA neurons, respectively. The VP is composed principally of GABAergic projection neurons (Root et al., 2015) , a sub-population of which label for the calcium-binding protein parvalbumin (PV). We labeled sections through the VP for PV and quantified the fraction of Rb-mCherry-labeled cells that co-label for PV. Though not reaching statistical significance in our small sample size, VTA dopamine neurons tend to receive more input from PVlabeled cells per starter neuron ( Figure 6A ), suggesting that PV neurons may play a specialized role in the control of dopamine neurons.
The largest two inputs to the VTA were from the DR and LH, and from these regions, we observed no significant difference by transmitter-defined cell type ( Figure 4C ). However, the DR and LH are composed of heterogeneous populations of projection neurons, and subpopulations of neurons may preferentially target transmitter-defined VTA neurons. In the LH, we characterized two subpopulations of neurons using the peptide markers melanocortin-concentrating hormone (MCH) and orexin (also called hypocretin), each of which labeled only a small fraction of Rb + VTA inputs from LH. The number of orexin co-labeled LH inputs per VTA starter cell was greater in the VGLUT2-Cre and DAT-Cre compared to VGAT-Cre mice ( Figure 6B ). In the case of MCH, a lower ratio of Rb/MCH inputs per starter cell was also observed for the VTA GABA population but again did not reach statistical significance ( Figure 6B ).
As noted earlier, VTA dopamine neurons received a smaller fraction of their inputs from the PPTg and LDTg when compared to glutamate and especially GABA neurons ( Figure 4C ). The PPTg and LDTg are well-known sources of cholinergic projection neurons, though GABA and glutamate neurons are also abundant, cholinergic neurons represent $25% of the total (Wang and Morales, 2009). However, the number of Rb-mCherry + cells co-positive for ChAT did not differ as a function of starter cells ( Figure S4A ). The DR was the largest single source of inputs to the VTA in our study. Known best for its serotonin neurons, the DR and median raphe (MnR) also contain large populations of GABA and glutamate projection neurons (Gocho et al., 2013) . We therefore labeled for TpH to identify the proportion of serotonergic inputs by VTA cell type ( Figure S4B ), though no significant differences were observed.
DISCUSSION
Using classical tracers, neuroanatomists have described VTA connectivity to and from a multitude of brain regions (Bjö rklund and Dunnett, 2007; Carr and Sesack, 2000; Fields et al., 2007; Geisler and Zahm, 2005; Ikemoto, 2007; Phillipson, 1979; Swanson, 1982) . However, as we begin to appreciate the physiological and behavioral relevance of VTA heterogeneity in behavior and disease (Fields et al., 2007; Lammel et al., 2014; Volman et al., 2013) , it becomes crucial to understand how heterogeneous VTA cell types are controlled via afferent connectivity. Modern tracing vectors coupled with mouse genetics make it possible to subsect across various dimensions of heterogeneity and trace connections; indeed, two recent studies have focused on projection target-defined VTA dopamine neurons Menegas et al., 2015) . However, the VTA also contains sizable populations of GABA and glutamate-releasing neurons that play discrete roles in regulating reward-related processes.
In this study, we provide a comprehensive description of inputs to each of these neurotransmitter-defined VTA cell types. To our surprise, we found that each of these transmitter-defined populations receive qualitatively similar afferent input. Nonetheless, quantitative differences were observed, with glutamate neurons tending to receive proportionally more input from cortical regions, dopamine neurons from basal ganglia, and GABA neurons from the lateral habenula and LDTg. Further, comparing the ratio of inputs to starter cells reveals that inputs to VTA GABA neurons show more convergence, consistent with a more uniform model of afferent control. The most pronounced finding in our study is that the organization of afferent input to VTA is qualitatively independent of transmitter-defined VTA cell type. This is counter to our initial hypothesis that excitatory, inhibitory, and neuromodulatory VTA cell types that convey distinct types of reward-relevant information might receive highly distinctive patterns of afferent input. However, our results are generally concordant with recent studies using similar approaches to compare the inputs to dopamine neurons defined by their projection target. Those studies did identify some distinctive connections to subpopulations of dopamine neurons that target the lateral NAc or posterior striatum (Menegas et al., 2015) but overall indicated that inputs to projection-target defined VTA dopamine neurons were quite similar.
Though qualitative similarity was the rule, we did identify several significant quantitative differences. For example, though the cortex provides a proportionally small and diffuse input to VTA, cortical regions as a whole make more inputs per starter cell on to VTA glutamate neurons. These inputs come from a variety of cortical regions, predominantly the somatosensory, motor, insular, and cingulate cortices. That proportionally few input cells were observed in cortical regions appears to be compatible with earlier whole-brain quantitative approaches (Geisler and Zahm, 2005; Phillipson, 1979) . The small number of input cells observed in the anterior cortex could be interpreted in different ways: (1) cortical inputs may be relatively less influential than subcortical inputs to VTA, (2) relatively few cortical neurons could make strong or large numbers of synapses, and (3) cortico-VTA synapses may be less efficiently labeled using our tracing strategy. Indeed, the high sensitivity of Rb-based approaches may lead to overweighting the implied influence of afferent regions that contain many connected cells with low synaptic incidence, whereas regions that may contain fewer connected cells but with high synaptic incidence, or making synapses resistant to transsynaptic spread, could be underweighted. We also find that basal ganglia nuclei, including the shell and core regions of the NAc as well as the dorsal striatum (CPu) and external globus pallidus (LGP), each provide proportionally more input to dopamine compared to non-dopamine VTA neurons. This finding is in apparent contradiction to optogenetic circuit-mapping studies that found that NAc projection neurons preferentially target non-dopamine VTA neurons (Bocklisch et al., 2013; Xia et al., 2011) . It is possible that the NAc to VTA dopamine projections we and others have identified anatomically Bolam and Smith, 1990; Grace and Bunney, 1985; Lerner et al., 2015; Menegas et al., 2015; Watabe-Uchida et al., 2012 ) synapse on to distal dopamine dendrites absent in the horizontal slice preparations, differ across species, or are primarily peptidergic.
VGAT + neurons in the VTA also display several distinct features when compared to DAT + and VGLUT2 + neighbors. First, they tend to receive more convergent input, i.e., fewer input cells per starter cell when more starter cells are labeled. This suggests that afferent control over VTA GABA neurons is more homogenous, and consequently, GABA output may function in a more uniform manner. Indeed, we also report here that VTA GABA neurons receive proportionally more input from the LHb. Although we find that LHb does not entirely avoid VTA dopamine and glutamate neurons, this finding is very much consistent with current models where LHb functionally inhibits VTA dopamine neurons through feed-forward activation of GABA neurons (Balcita-Pedicino et al., 2011; Brinschwitz et al., 2010; Proulx et al., 2014) . We also observed a proportionally larger input from the LDTg to VTA GABA neurons, which is interesting in light of the observation that photostimulation of a mixed LDTg input to VTA was sufficient to drive a dopamine-dependent conditioned place preference (Lammel et al., 2014) , potentially highlighting that the proportional weight of an input region need not correlate with functional importance.
The most abundant inputs irrespective of cell type were from DR, LH, and ventral pallidum. We used immunohistochemical approaches to immunochemically identify subpopulations of neurons, these observations did not reach statistical significance once corrected for multiple comparisons. This highlights important limitations of our study and previous studies using similar approaches to quantitatively compare VTA inputs: low sample size, large numbers of measurements, and consequently low statistical power for group comparisons. The VTA receives inputs from a large number of brain regions, and thus several hundred measurements are made per group; these measurements range across several orders of magnitude, limiting the utility of statistical tests that rely on normality. We thus limited our quantitative assessments to two approaches. One-way ANOVAs were used to compare the three genotypes within equi-variant regions followed by a Tukey post hoc correction for multiple comparisons. This approach applies separate ANOVAs across each brain region and fails to consider the dataset in its entirety.
Because of the small sample size and large number of comparisons, we also applied methods developed to probe changes in gene expression across groups . This approach leverages information across region in estimating the parameters of negative binomial generalized linear models fit to each region. This analysis, represented in Figure 5 (see also the Supplemental Experimental Procedures and Tables S1-S6), allows for pairwise comparisons of inputs across region and cell type and produced results highly concordant with ANOVA. Beier et al. (2015) recently published a report comparing inputs to VTA dopamine versus GABA neurons. Although the overall pattern and respective weights of the afferents were similar across our studies, there are several notable differences. As discussed above, we find that striatal regions preferentially target dopamine neurons while GABA neurons receive proportionally more input from LHb and LDTg, whereas the previous study reported no significant differences between these cell types. Several methodological differences could contribute to this, including our use of different Cre-driver lines, viral serotypes, and promoters or differences in the number and location of starter cells. Potentially relating to the latter is our strategy of injecting AAV-TVA helper virus diluted by two to three orders of magnitude compared to previous studies targeting VTA cell types. We adopted this strategy to limit the potential for low-level expression of TVA outside of the VTA due to spread or retrograde transport of AAV or outside of the cell type of interest due to a leak in TVA expression from the DIO cassette. Indeed, although the pseudotyped Rb vector we used produced no detectable mCherry expression when injected into mice not previously injected with helpers, copious mCherry + cells were present at the injection site in wild-type mice (lacking Cre) previously injected with ''stock'' concentrations (i.e., >10 12 ) of helper AAVs. That we did not find Rb-mCherry expression at sites distal to the VTA or evidence of TVA:YFP or RbG-BFP fluorescence within the VTA suggests that very low-level Cre-independent ''leak'' expression of TVA:YFP suffices for entry of pseudo-typed Rb-mCherry but that higher Cre-dependent expression of RbG is required for transsynaptic spread (Miyamichi et al., 2013; Weissbourd et al., 2014) . By selecting a highly diluted concentration of AAV-TVA, we minimized the potential for primary infection by Rb-mCherry in Cre-negative cells and increased the proportion of starter cells restricted to the VTA. However, this strategy also reduces the total number of starter cells that may introduce greater sampling bias. Another difference between our approach and that taken in prior studies is our use of a bicistronic AAV helper vector to express histone-bound (i.e., nuclear) FLAGtagged BFP in RbG-expressing cells. Because it is the expression of the RbG that allows for transsynaptic spread, any neuron expressing Rb-mCherry and RbG-BFP will function as a starter cell, whether or not it expresses TVA or was infected by primary (i.e., injected Rb-mCherry) or subsequently by Rb-mCherry amplified in vivo.
Using this approach, we were able to target an equivalent number of starter cells for each of the three cell types. Though our injections were medially biased to focus on the VGLUT2 + population, these results suggest that the relative proportions of these cell types, especially in medial VTA, may be more balanced than generally appreciated. Indeed, estimates of VGLUT2 + VTA cells vary greatly depending on the approach used (Kawano et al., 2006; Nair-Roberts et al., 2008; Yamaguchi et al., 2011) , and Cre-dependent AAV-mediated expression may be particularly sensitive to low expression levels. Additionally, the ability of VTA neurons to co-release multiple transmitters dictates that some cells will be represented in more than one group. In this study, we found that 18.4% ± 4.5% of VGLUT2 + starter cells labeled for the dopamine neuron marker TH, likely contributing to the similarity between inputs received on to DAT + and VGLUT2 + cell types. Dopamine neurons can also co-release GABA, but GABA co-release relies on non-canonical mechanisms of GABA synthesis and vesicular packaging (Kim et al., 2015; Tritsch et al., 2012) , and we found that <1% of VGATCre starters co-labeled for TH. Selective labeling of and tracing of inputs only to neurons that express both dopamine and glutamate markers, or to glutamate, but not dopamine, markers, would be of great interest but will require the development of new mouse driver lines and viral vectors.
In summary, we showed that VTA glutamate, dopamine, and GABA neurons receive qualitatively similar but quantitatively distinct patterns of input from many and diverse brain regions. Dopamine and GABA neurons show several marked differences, while VGLUT2 + neurons are generally an intermediate between the two, which is perhaps an expression of their ability to corelease either dopamine or GABA. This work adds to our growing body of knowledge on the input/output relationship of VTA cell types and will be used to further unravel the functional importance of distinct mesolimbic sub-circuits. Understanding how distinct populations of anatomically and neurochemically distinct circuits are connected to control behavior promises to provide opportunities to treat intractable mental illness such as addiction. (stock no: 006660) . Control mice were wild-type littermates obtained by back-crossing with C57Bl/6 mice (The Jackson Laboratory). Note that VGLUT2-Cre and DAT-Cre were fully backcrossed to C57Bl/6 but VGAT-Cre mice are on a mixed 129Sv x C57Bl/6. Mice were bred at UCSD, group housed, and maintained on a 12h light-dark cycle with food and water available ad libitum. Both male and female mice were included and all experiments performed in accordance with protocols approved by the University of California San Diego Institutional Animal Care and Use Committee. Viruses and stereotaxic surgery. Plasmid construction and virus production of Rb-∆G-mCherry were described in our previous studies . For construction of pAAV-CMVSyn-DIO-TVA950-EYFP, CMV enhancer and synapsin I promoter were cloned by PCR (Hioki et al., 2007) .TVA950 was fused with EYFP with In-Fusion reaction. For construction of AAV1-EF1α-DIO-H2B-tagBFP-Flagx3-T2Am-cB19G, N-terminus and C-terminus of tagBFP were fused with Histone 2B and three tandem FLAG epitopes, respectively. ORF of rabies glycoprotein was codon-optimized for mice and humans and synthesized to obtain cB19G. The N terminus and C-terminus of T2A were modified by addition of GSG and APGS, respectively (Tang et al., 2009 ). Rb and AAV vectors were obtained from the Salk Gene Transfer Targeting and Therapeutics Core. For intracranial injection, mice (5-6 weeks old) were deeply anesthetized with isoflurane, placed in a 1900-model Kopf Stereotaxic apparatus (Kopf Instruments, Tujunga, California) and 200 nL of 1:1 mixture AAV2/1-CMVeSyn-DIO-TVA950-EYFP (AAV-TVA; 2.4 x 10 10 GC/mL unless noted) and AAV2/1-EF1α -DIO-H2B-tagBFP-Flagx3-T2Am-cB19G (AAV-RbG; 1.1 x 10 13 GC/mL) prepared in HBSS 1X (Hanks' balanced salt solution, Gibco), infused unilaterally into the left hemisphere VTA (LM= -0.4, AP= -3.4, DV= -4.4; mm relative to Bregma) at 100 nl/min (WPI UltraMicroPump) using custom-made 30-gauge stainless (Plastics One, VA) injectors. The injection tip was left in place for an additional 10 min then slowly retracted. Animals were allowed to recover for 3 to 4 weeks to enable optimal virus expression. Then 125 nL of EnvA-Rb-ΔG-mcherry (Rb-mCherry; 5 x 10 7 TU/mL) were injected at the same stereotaxic coordinates following the same procedure. Control experiments included injections of these 3 viruses in wild-type littermates, injection of only Rb-mCherry in Cre-expressing animals, and injection of only AAV-TVA and Rb-mcherry in each of the Creexpressing mouse lines. Histology. Seven days after injection of Rb-mCherry, mice were deeply anesthetized with a mixture of ketamine (Pfizer, 10 mg/kg i.p.) and xylazine (LLOYD, 2 mg/kg i.p.) and transcardially perfused with 10 ml of phosphate buffered saline (PBS) followed by 50 ml 4% paraformaldehyde (PFA) at a rate of 5-6 ml/min. Brains were extracted, incubated in 4% PFA at 4ºC overnight then transferred to 30% sucrose solution in PBS for 48 to 70 hours at 4ºC. Brains were snap frozen in isopentane and stored at -80ºC. For quantitative assessments, 30-µm coronal cryo-sections were cut using a cryostat (CM3050S, Leica) and collected in a solution of 0.01% sodium azide PBS. An additional cohort of animals was used to collect 50-µm sagittal cryo-sections for visualization but were not counted.
For immunostaining, brain sections were gently rocked and washed 3x 5 min in PBS, 3x 5 min in PBS containing 0.2 % triton X-100 (PBS-Tx), and blocked with 4% normal donkey serum (NDS) in PBS-Tx (blocking) for 1 hour at room temperature (RT). Sections were then incubated in blocking solution at 4ºC overnight using one or more of the following primary antibodies: rabbit anti-TH, 1:2000, Millipore AB152; sheep anti-TH, 1:2000, Pel-Freez P60101-0; mouse anti-Flag M2, 1:2000, Sigma F3165; goat anti-ChAT, 1:400, Millipore AB144P; sheep anti-αTpH (αTryptophan hydroxylase), 1:2000, Pel Freeze P60401-0; rat anti-substance P, 1:400, Millipore MAB356, mouse anti-parvalbumin, 1:2000, Millipore MAB1572; goat anti-Orexin-A (C-19), 1:1000, Santa Cruz Biotechnology sc-8070, goat anti-pro-MCH (C-20), 1:1000, Santa Cruz Biotechnology sc-14509; mouse antiOxytocin, 1:500, Millipore MAB5296. Sections were rinsed 3x 10min with PBS-Tx and incubated in appropriate for 2 hr at RT. Sections were washed 3x 10 min with PBS, mounted on to slides and coverslipped with Fluoromount-G mounting medium (Southern Biot Imaging. Images for counting starter cells were acquired with a 4x magnification (NA: 0.16) objective using an Olympus BX53 epifluorescence microscope (equipped with a Hamamatsu ORCA-Flash4 camera) and CellSens dimension 1.12 software and at 10x magnification (NA: 0.45) objective using a Zeiss AxioObserver Z1 widefield epifluorescence microscope and Zen blue Zeiss software (2012 version). Afferent input counting and most of the immunohistochemical characterization of afferent inputs was realized on images acquired with the slide scanner NanoZoomer 2 HT and fluorescence module L10387-03 (Hamamatsu Photonics, Japan). Acquisition was performed using a dry 20x objective (NA: 0.75). 40x resolution was achieved with a lens converter. Images for immunohistochemical characterization were also acquired using the Zeiss AxioObserver Z1 widefield epifluorescence microscope at 10x (NA: 0.45) and 20x (NA: 0.75) magnifications. ApoTome 2.0 technology was used with 20x objective for structured illumination.
Cell counts. Counting of starter cells, afferent input cells and immunohistochemically-characterized cells was conducted manually on one 30-µm section every 150µm along the rostral caudal extent of the brain. Starter cells in the VTA were counted manually and blindly using the cell counter plugin of ImageJ software from Bregma -2.8mm to -4.36mm. Cells were considered as starter cells when expressing native cytoplasmic mCherry fluorescence (EnvA-Rb-ΔG-mCherry) and nuclear immunolabel against the Flag epitope on RbG (AAV2/1-EF1α-DIO-hBFP-Flagx3-T2Am-B19G). Five to six animals per group were injected with the helper AAV and Rb vectors. Coronal sections for starter cell counts were co-labeled with TH to assist in drawing VTA boundaries. Whole-brain labor-intensive cell counts were not completed on mice presenting large numbers of starter cells outside of the VTA. The remaining 3-4 animals used per group presented none or less than 3% starter cells outside the VTA for GABA and glutamate-expressing starter cells, and less than 10% for dopamine-expressing starter cells. For the DAT-IRES-Cre, VGLUT2-IRES-Cre and VGAT-IRES-Cre animals respectively rare or few starters were observed; in the substantia nigra pars compacta (SNC) and the retrorubral field (A8); in the supramammillary nucleus (SuM) and posterior hypothalamus (PH); and in the interpeduncular nucleus (IP) (File S1). Tyrosine Hydroxylase (TH)-positive starter cells were counted on the same sections and identified as TH positive when soma and cell processes fully overlapped for TH immunolabel and native mCherry.
Afferent inputs were manually and blindly counted on screen using the NDP viewer with an integrated high-resolution zoom and equipped with a counting tool. Counting was realized from Bregma +2.8mm to -5.8mm on 53 +/-0.5 sections. Neurons were considered as VTA afferent inputs when the red fluorescence (mCherry) was filling objects that showed clear borders and processes. Regions were identified by a single investigator and using the Paxinos Mouse Brain Atlas (Paxinos & Franklin 2001) as reference. Regions were grouped into areas and subareas based on the Allen Brain Atlas classification (http://mouse.brain-map.org/).
Immunochemical characterization of inputs was performed manually and blindly using the NDP viewer and/or the cell counter plugin of ImageJ. Cells were considered immunopositive for a specific marker when the AlexaFluor488 (fluorophore of the secondary antibody immunolabel) was clearly overlapping mCherry. ChAT immunofluorescence was counted in the PPTg from Bregma -4.2 mm to -5.0 mm; and in the LDTg from Bregma -4.8 mm to -5.5 mm. TpH immunoreactivity was measured in the DR from Bregma -4.0 mm to -5.3 mm; and in the MnR from Bregma -4.0 mm to -5.0 mm. In the LH, we used separate sections to assess Orexin or MCH expression from Bregma -0.3 mm to -2.8 mm. Parvalbumin staining in the VP was counted from Bregma +1.9 mm to -0.3 mm. Statistics. All data were assessed using one-way ANOVA with cell type as a factor and Tukey's posthoc test to correct for multiple comparisons. Because different regions had widely variable inputs to VTA, we used two complimentary approaches to analyze differences in the proportions of input each area/region sends to each VTA cell type. As represented in Figure 4 , we ran one-way ANOVAs with Tukey's posthoc test to correct for multiple cell-type comparisons on each of the seven areas assessed and select sub-areas or regions (representing the top 25 inputs). No corrections were made to account for running these 32 ANOVAs. As represented in Figure 5 we adopted a transcriptomic analysis strategy to model the difference in cell counts between each group within each area, subarea, or region. In light of possible overdispersion, we fitted negative binomial models using the methods of Love, Huber, and Anders and the package DESeq, and report each pairwise comparison (i.e. DAT-Cre vs. VGAT-Cre, DAT-Cre vs. VGLUT2-Cre, and VGAT-Cre vs. VGLUT2-Cre). Size factors are estimated and passed as offset terms in the procedure implemented in the DESeq package available for the R statistical programming language as follows: given cell count kij for sample j (j = 1, ..., m) on class i (here, class is synonymous with area / subarea / subregion), the size factor sj for sample j is estimated as
